Anúncio
Anúncio
PRAX
Praxis Precision Medicines, Inc. Common Stock
286.58
USDPatrocinado
-8.16
-2.77%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
286.57
0.00
0.00%
Relatórios de Lucros PRAX
Rácio de surpresa positiva
PRAX separação 9 de 21 últimas estimativas.
43%
Próximo Relatório
Data do Próximo Relatório
26 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$51.00K
/-$3.13
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-6.85%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-99.32%
/+6.46%
Praxis Precision Medicines, Inc. Common Stock earnings per share and revenue
On 05 de nov. de 2025, PRAX reported earnings of -3.36 USD per share (EPS) for Q3 25, beating the estimate of -3.51 USD, resulting in a 4.30% surprise. Revenue reached --, compared to an expected 39.23 mil, with a -100.00% difference. The market reacted with a -4.14% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -3.13 USD, with revenue projected to reach 51.00 mil USD, implying an diminuir of -6.85% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Praxis Precision Medicines, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Praxis Precision Medicines, Inc. Common Stock reported EPS of -$3.36, beating estimates by 4.3%, and revenue of $0.00, -100% below expectations.
How did the market react to Praxis Precision Medicines, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.14%, changed from $171.75 before the earnings release to $164.64 the day after.
When is Praxis Precision Medicines, Inc. Common Stock expected to report next?
The next earning report is scheduled for 26 de fev. de 2026.
What are the forecasts for Praxis Precision Medicines, Inc. Common Stock's next earnings report?
Based on 17
analistas, Praxis Precision Medicines, Inc. Common Stock is expected to report EPS of -$3.13 and revenue of $51.00K for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio